Sen A, Chen Y D, Yan B, Chalovich J M
Department of Biochemistry, Brody School of Medicine at East Carolina University, Greenville, North Carolina 27858-4354, USA.
Biochemistry. 2001 May 15;40(19):5757-64. doi: 10.1021/bi002724t.
Equilibrium measurements of the rate of binding of caldesmon and myosin S1 to actin-tropomyosin from different laboratories have yielded different results and have led to different models of caldesmon function. An alternate approach to answering these questions is to study the kinetics of binding of both caldesmon and S1 to actin. We observed that caldesmon decreased the rate of binding of S1 to actin in a concentration-dependent manner. The inhibition of the rate of S1 binding was enhanced by tropomyosin, but the effect of tropomyosin on the binding was small. Premixing actin with S1 reduced the amplitude (extent) of caldesmon binding in proportion to the fraction of actin that contained bound S1, but the rate of binding of caldesmon to free sites was not greatly altered. No evidence for a stable caldesmon-actin-tropomyosin-S1 complex was observed, although S1 did apparently bind to gaps between caldesmon molecules. These results indicate that experiments involving caldesmon, actin, tropomyosin, and myosin are inherently complex. When the concentration of either S1 or caldesmon is varied, the amount of the other component bound to actin-tropomyosin cannot be assumed to remain fixed. The results are not readily explained by a mechanism in which caldesmon acts only by stabilizing an inactive state of actin-tropomyosin. The results support regulatory mechanisms that involve changes in the actin-S1 interaction.
来自不同实验室的关于钙调蛋白和肌球蛋白S1与肌动蛋白-原肌球蛋白结合速率的平衡测量得出了不同的结果,并导致了关于钙调蛋白功能的不同模型。回答这些问题的另一种方法是研究钙调蛋白和S1与肌动蛋白结合的动力学。我们观察到钙调蛋白以浓度依赖的方式降低了S1与肌动蛋白的结合速率。原肌球蛋白增强了对S1结合速率的抑制作用,但原肌球蛋白对结合的影响较小。将肌动蛋白与S1预混合会按与含有结合S1的肌动蛋白比例降低钙调蛋白结合的幅度(程度),但钙调蛋白与游离位点的结合速率没有太大改变。尽管S1显然确实结合在钙调蛋白分子之间的间隙处,但未观察到稳定的钙调蛋白-肌动蛋白-原肌球蛋白-S1复合物的证据。这些结果表明,涉及钙调蛋白、肌动蛋白、原肌球蛋白和肌球蛋白的实验本质上是复杂的。当S1或钙调蛋白的浓度发生变化时,不能假定与肌动蛋白-原肌球蛋白结合的另一种成分的量保持不变。这些结果很难用一种钙调蛋白仅通过稳定肌动蛋白-原肌球蛋白的非活性状态起作用的机制来解释。这些结果支持了涉及肌动蛋白-S1相互作用变化的调节机制。